Hearken to this text |
ZAP Surgical Techniques Inc. this week mentioned it has efficiently closed a $78 million Sequence E funding spherical. The developer of non-invasive, robotic brain-surgery instruments mentioned the brand new financing will advance the commercialization of its ZAP-X Gyroscopic Radiosurgery platform.
Stereotactic radiosurgery (SRS) is a well-established process for the non-invasive remedy of many mind tumors together with mind metastases, meningiomas, and different intracranial problems reminiscent of trigeminal neuralgia. Thought-about an alternative choice to open surgical procedure for these indications, SRS is an outpatient process delivered in a single to 5 temporary therapies, in accordance with ZAP Surgical.
In comparison with open surgical procedure, nonetheless, the SRS process has confirmed to offer equal to superior outcomes, claimed the San Carlos, Calif.-based firm. It requires no surgical incision, inflicts no ache, and usually requires little to no affected person restoration interval, it added.
“We based ZAP Surgical to deal with a transparent want: enabling extra sufferers to entry state-of-the-art radiosurgery with out the prohibitive prices and infrastructure necessities that restrict so many suppliers,” said John R. Adler, M.D., professor emeritus of neurosurgery at Stanford College, in addition to founder and CEO of ZAP Surgical Techniques.
ZAP-X guarantees to develop care
Every year, greater than 5 million sufferers globally may benefit from stereotactic radiosurgery, estimated ZAP Surgical Techniques. Nevertheless, due to the fee and complexity of legacy applied sciences, solely about 200,000 sufferers obtain optimum SRS care, it mentioned.
With availability concentrated primarily amongst solely the most important city tutorial hospitals, world-class radiosurgery has remained out of attain for an estimated 96% of sufferers who may profit, mentioned the corporate.
ZAP Surgical has developed the ZAP-X platform, a devoted, non-invasive cranial radiosurgery system that includes superior gyroscopic know-how. Its motion permits radiosurgical beams to be directed from hundreds of potential angles for exact tumor focusing on.
The corporate mentioned its strategy prioritizes the safety of wholesome mind tissue and goals to protect affected person cognitive operate. As well as, it mentioned the vault-free and cobalt-free design of ZAP-X eliminates the necessity for pricey shielded remedy rooms and removes the standard requirement to handle, safe, and substitute radioactive isotopes for radiation beam manufacturing.
Baheal Medical companions with ZAP Surgical
Qingdao Baheal Medical Inc. led ZAP Surgical’s Sequence E spherical, which additionally included participation from different strategic traders. Baheal Medical is a number one healthcare firm in China.
“This partnership with Baheal Medical completely aligns with our mission, offering ZAP-X with a strong platform to achieve hundreds of thousands of underserved sufferers globally,” mentioned Adler.
“We’re thrilled to accomplice with ZAP Surgical in increasing entry to cutting-edge radiosurgery know-how,” added Fu Gang, chairman and president of Baheal Medical. “ZAP-X’s revolutionary strategy aligns with our dedication to delivering superior healthcare options that deal with urgent scientific wants. Collectively, we’re poised to advertise how mind tumors and different intracranial illnesses are handled, offering extra exact options that vastly improve sufferers’ high quality of life.”